Company Description
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States.
Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services.
As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts.
Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Country | Ontario, Canada |
Founded | 2011 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 492 |
Contact Details
Address: 890 Yonge Street, 7th Floor Toronto, A6 M4W 3P4 Ontario, Canada | |
Phone | 416-322-9700 |
Stock Details
Ticker Symbol | GBNHF |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001735948 |
ISIN Number | CA3937043097 |
SIC Code | 8090 |
Key Executives
Name | Position |
---|---|
Sasha Cucuz | Executive Chairman |
William P. Leonard | President, Chief Executive Officer and Director |
Dr. Geoffrey Garland Grammer M.D. | Chief Medical Officer |
Peter Willett | Chief Financial Officer |
Glen Akselrod | Investor Relations Officer |
Iris Krug | Vice President of Compliance and Privacy Officer |
Brittany Schwemmer | Vice President of Human Resources |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 23, 2024 | 8-K | Current Report |
Apr 19, 2024 | 8-K | Current Report |
Apr 8, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Apr 8, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Apr 2, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
Apr 1, 2024 | 25 | Filing |
Mar 29, 2024 | 8-K | Current Report |
Mar 26, 2024 | 8-K | Current Report |
Mar 15, 2024 | 8-K | Current Report |
Mar 8, 2024 | 8-K | Current Report |